Integrated positron emission tomography and computed tomography (PETyCT) scanning has become the standard for oncologic imaging. We sought to determine the role of PETyCT in mediastinal non-small cell lung cancer staging. One hundred and twenty-seven consecutive patients were enrolled in the study where PETyCT was performed due to pathologically defined non-small cell carcinoma from a single center. They all underwent complete resection with a thoracotomy and systemic lymph node dissection (SLND) between October 2005 and January 2007. Postoperative pathology results of lymph node stations regarding the nodal spread and stage were compared with clinical stage obtained by PETyCT. The sensitivity, specificity, accuracy, negative predictive value (NPV) and positive predictive value (PPV) of PETy CT in N2 cases were determined to be 72.0%, 94.4%, 92.7%, 97.7% and 49.2%, respectively. Maximum standard uptake (SUV ) cut-off value max for mediastinal N2 involvement in PETyCT was obtained by applying 'receiver operating characteristic' (ROC) analysis that was set to 5.2. Correct stage with PETyCT was established in 76.3% of cases. Staging of non-small cell lung cancer (NSCLC), according to the PETyCT for which we determined 97.79% NPV, we consider that thoracotomy without preoperative mediastinal invasive staging in cases of negative mediastinal involvement in PETyCT can be certainly performed.
Introduction
Analysis of the fluorodeoxyglucose (FDG) accumulation in the body detected by the positron emission tomography (PET) camera allows for differentiating malignant tissues. The important point in thoracic malignancies is to choose the best therapeutic strategy for patients who benefit from surgical resection or chemoradiotherapy w1, 2x.
PET has been shown to have a better definition of both the possibility of malignancy and mediastinal nodal involvement. The current integrated PETycomputed tomography (CT) scanning provide clear definition of the anatomical borders w3x. According to that, the negative predictive values (NPVs) were raised to 95-99% in some published series w4, 5x. The aim of the study was to evaluate the significance of integrated PETyCT enhancement in lymph node staging in patients with non-small cell lung cancer (NSCLC) as well as to question to what extent PETyCT may bypass mediastinoscopy. Therefore, this study is the analysis of our clinical experience regarding discussion of the value of PETyCT in mediastinal staging.
Patients and methods
One hundred and twenty-seven cases that were diagnosed as NSCLC between October 2005 and January 2007 were included in the study. PETyCT results were compared with postoperative pathology in 826 lymph node stations obtained from systemic lymph node dissection (SLND).
All patients underwent standard preoperative tests including past medical history, physical examination, blood tests and spirometry. Radiological tests were done by performing chest radiography, chest computed tomography and PETy CT. Patient characteristics included age, sex, tumor histology, tumor diameter and localization as either peripheral or central, positive lymph nodes on CT and PETyCT, the findings after mediastinal investigation and thoracotomy and pathologic stage; these were recorded according to the Mountain staging TNM system w6x. The ࠻10 and ࠻11 stations were taken into consideration as N1 lymph node station and ࠻2, ࠻4, ࠻5, ࠻6, ࠻7, ࠻8 and ࠻9 stations as N2 lymph node station. ࠻2, ࠻4 and ࠻7 stations showing positive involvement at PETyCT were verified by mediastinoscopy and ࠻5, ࠻6, ࠻8, ࠻9 stations were verified by videothoracoscopy.
Exclusion criteria are as follows:
• 65 mgydl -fasting blood glucose )150 mgydl • Type I diabetes mellitus Thoracotomies with SLND were performed to all PETyCT (-) cases for nodal spread. Mediastinoscopy were performed in cases that were PETyCT (q) at ࠻2R, ࠻2L, ࠻4R, ࠻4L and ࠻7 nodal stations. 'Frozen sections' (FyS) of lymph nodes that were sampled by mediastinoscopy were done. Thoracotomy with SLND was applied to the cases with negative FyS results. The cases with a positive FyS were further directed to neoadjuvant or adjuvant therapy due to the characteristics of nodal involvement. Sampling was obtained by video assisted thoracoscopy in cases that were PETyCT (q) at ࠻5, ࠻6, ࠻8, ࠻9 nodal stations. Same evaluation of nodal spread was performed. Intraoperative SLND was performed as described by Goldstraw w7x. The description was considered for the side as ࠻2, ࠻4, ࠻7, ࠻8, ࠻9, ࠻10, ࠻11 nodal stations and on the left ࠻5, ࠻6, ࠻7, ࠻8, ࠻9, ࠻10 and ࠻11 nodal stations. Surgical interventions of all patients were performed by three senior consultants in the same clinic.
PETyCT imaging protocol
Patients were imaged on a Biograph (SiemensyCTI) scanner. This system produces transaxial, coronal, and sagittal reconstructions of CT, PET, and fusion PETyCT data for interpretation. The Biograph scanner combines a dualdetector spiral CT scanner (Somatom emotion) and a highresolution PET scanner with 4.5-mm spatial resolution and 3-dimensional image acquisition. A multimodality computer platform (Syngo; Siemens) is used for image review and manipulation. After the patients had fasted for at least 6 h, they received ;555 MBq (15 mCi) of F-FDG by intra-18 venous injection. The total acquisition time ranged from 25 to 35 min per patient. The CT data were used for attenuation correction of PET emission images and for anatomic localization of emission data.
PETyCT images of all patients included in the study were taken in the same unique center and assessed by the same nuclear medicine expert (OF).
Statistical analysis
Statistical analysis of data was performed by Statistical Package for Social Sciences (SPSS) for Windows 10.0. 'Receiver operating characteristic' (ROC) analysis was applied to determine the value that we could use as a 'cutoff' value. The results were evaluated with a 95% confidence interval and at a significance level of P-0.05.
Results
Among those patients, 98 of them (77.1%) were male and the mean age was 58.2 (41-82) years. Histopathological examination revealed that 69 cases (54.3%) were squamous cell carcinoma, 54 (42.5%) cases were adenocarcinoma and four (3.14%) cases were large cell carcinoma. The average interval between PETyCT scanning and the operation date was 19 days (1-30 days).
Thoracotomy without invasive staging was performed in 91 of 127 cases (71.6%) which were negative nodal spread on PETyCT. Two cases were inoperable due to N2 nodal involvement. Invasive staging was performed with mediastinoscopy in 31 of 36 cases with positive involvement at PETyCT. Video assisted thoracoscopic staging was performed in five cases. Mediastinal nodal involvement was determined in 12 of 31 cases staged with mediastinoscopy and three out of five cases were staged with video assisted thoracoscopy (involvement in ࠻8, ࠻9 stations). The following procedures were performed in 108 cases; wedge resection in one case due to insufficient pulmonary reserve, lobectomy in 73, bilobectomy in six, sleeve lobectomy in seven, pneumonectomy in 18 and sleeve pneumonectomy in three cases.
According to patient-based assessment, when PETyCT was compared with pathological results, it was determined that PETyCT has a true-negative (TN) result in 89 cases, a falsenegative (FN) result in two cases, a true-positive (TP) result in 17 cases and a false-positive (FP) result in 19 cases. These results yielded a sensitivity of PETyCT of 88.8%, a specificity of 81.6%, accuracy of 82.6%, a negative predictive value (NPV) of 97.8% and a positive predictive value (PPV) of 44.4%.
In lymph node station-based assessment, the results of 826 lymph node stations (220 N1, 606 N2) in 127 cases were compared with pathological results. The statistical analysis of PETyCT of all mediastinal lymph node stations (N1qN2) regarding nodal staging is shown in Table 1 .
'ROC' analysis was applied to the results for N2 mediastinal lymph node stations and we obtained the sensitivity, specificity, PPV, NPV, accuracy and relative risk value and '5. 
False-positive involvement
The distribution of 32 lymph node stations with FP involvement at PETyCT that were determined not to be carcinoma invasion after pathological assessment were: 25 (4.12%) granulomatous inflammation mostly in stations ࠻4 and ࠻7, reactive hyperplasia in five, one silicosis and one tuberculosis lymphadenitis.
Consistency between PETyCT positive involvement and pathology
There is a statistically significant correlation between PETyCT positivity and pathological positivity at ࠻2 lymph node station (P: 0.453; P)0.05); ࠻5 lymph node station (P: 1.000; P)0.05); ࠻6 lymph node station (P: 1.000; P)0.05); ࠻8 lymph node station (P: 1.000; P)0.05) and ࠻9 lymph node station (P: 1.000; P)0.05). However, no statistically significant correlation was obtained in lymph nodes ࠻4 (P: 0.021; P-0.05) and ࠻7 (P:0.001; P-0.05) ( Table 3) . Clinical stages according to PETyCT (cTNM) were compared with postoperative staging (pTNM) for nodal spread. Fifteen cases (11.8%) were found to be lower stage, 15 cases (11.8%) higher stage and 97 cases (76.4%) the same stage.
Discussion
Recent studies on mediastinal staging via CT have shown to have unsatisfactory results. PET has been shown to have a better definition of both the possibility of malignancy and mediastinal nodal involvement. One of the most frustrating aspects of FDG PET alone is the lack of anatomic detail and the uncertainty in localizing many areas of FDG accumulation. It is often difficult or impossible to differentiate specific areas of FDG uptake as physiologic or pathologic. Therefore, a combined PET and CT scanner into a single unit amounts to advantages that are not merely additive, but synergistic w2, 3x.
Large-scale studies confirm that the sensitivity and specificity is 74% and 85%, respectively w4, 5x, with certainly higher NPVs. In the current integrated PETyCT, the scanning definition of the anatomical borders became clear. CT scanning has an inadequate ability in confirming mediastinal metastasis.
Schimmer et al. w8x published a Medline search under the topic of 'positron emission tomography andyor mediastinoscopy' and found 448 original studies and a review. In the review, while they reported that sensitivity was 58-94%, specificity 76-96%, PPV 43-95%, NPV 56-98% and accuracy 74-91% for PETyCT, and sensitivity was 80-96%, specificity 100%, PPV 92-97% and NPV 94% for mediastinoscopy.
Studies indicate that patients incorporating with PETyCT can reduce the number of unnecessary thoracotomies. However, we wish to go further and to conclude whether routine mediastinoscopy can be omitted in negative mediastinal FDG-PETyCT. NPVs are in a different range from study to study between 88% and 95% w5, 9, 10x.
It has been shown that integrated PETyCT improves the diagnostic accuracy of staging in NSCLC w11, 12x. The present study determined that the NPV is as high as 98%, where sensitivity, specificity, PPV and accuracy was 73%, 95%, 49%, and 93%, respectively, for PETyCT.
Some and ࠻9 stations). This is consistent with another study performed by Truong et al. w14x . They advocate that this may be due to higher metabolic activity in brown adipose tissue around posterior lymph nodes. In our study, while 12 lymph node stations were showing negative involvement at PETyCT, these were determined to be positive after a histopathological investigation. Four of these 12 lymph node stations were ࠻7 stations and their diameters were -7 mm. Primary tumors were localized centrally in these cases. In one of our cases, while the ࠻4 lymph node sampled by mediastinoscopy was negative following FyS, it was determined to be positive after immunohistochemical staining. The diameters of the other seven lymph nodes were -5 mm.
According to the FP results, histoplasmosis infection and silicosis were reported w13, 15x. The present series determined 25 granulomatous inflammations (78.1%) out of 32 FP mediastinal involvements at PETyCT. It was reported that the causes for FP involvements were changing from country to country. Another factor that answers the variability is the quality of CT scanners installed within PETyCT units and many different CT protocols in use.
Conclusions
We consider that PETyCT with values reaching to NPV 98% and ACC 93% is consistent with mediastinoscopy with values of NPV 96% and ACC 97% and direct thoracotomy should be performed without any need for invasive staging in case of no positive involvement in mediastinal lymph node stations at PETyCT, but histopathological verification should certainly be done in case of positive involvement.
